Analyst Research

Report Title Price
Trading Report for (AET). A detailed report, including free correlated market analysis, and updates.
Provider: Stock Traders Daily
$58.00
Buy
Aetna Inc (AET) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratios and Financial Averages
Provider: Plunkett Research, Ltd.
$99.00
Buy
Thomson Reuters Stock Report - AETNA INC. (AET-N)
Provider: Thomson Reuters Stock Report
$25.00
Buy
ValuEngine Detailed Valuation Report for AET
Provider: ValuEngine, Inc.
$127.00
Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

» More Analyst Research

Aetna Inc Reaffirms FY 2012 EPS Guidance; Issues FY 2013 EPS Guidance Below Analysts' Estimates; Reaffirms Long Term EPS Guidance-Conference Call


Wednesday, 12 Dec 2012 02:00pm EST 

Aetna Inc announced that it expects to end fiscal 2012 at $5.10 per share and next year (fiscal 2013), $5.40 at least, which will give a 13.6% CAGR since 2010. And the Company believe that it can continue to commit to low double-digit operating EPS growth on average over time. According to I/B/E/S Estimates, analysts are expecting the Company to report EPS of $5.51 for fiscal 2013. 

Latest Developments for Aetna Inc

Latest Key Developments in Insurance

Company Quote

Aetna Inc
(AET.N)
59.39
-1.0 -1.66%
11:14am EDT